| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |